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Background: The decision aids for diabetes (DAD) trial explored the feasibility of testing the effectiveness of
decision aids (DAs) about coronary prevention and diabetes medications in community-based primary care
practices, including rural clinics that care for patients with type 2 diabetes.
Methods: As originally designed, we invited clinicians in eight practices to participate in the trial, reviewed the
patient panel of clinicians who accepted our invitation for potentially eligible patients, and contacted these patients
by phone, enrolling those who accepted our invitation. As enrollment failed to meet targets, we recruited four new
practices. After discussing the study with the clinicians and receiving their support, we reviewed all clinic panels for
potentially eligible patients. Clinicians were approached to confirm participation and patient eligibility, and patients
were approached before their visit to provide written informed consent. This in-clinic approach required study
coordinators to travel and stay longer at the clinics as well as to screen more patient records for eligibility. The
in-clinic approach was associated with better recruitment rates, lower patient retention and outcome completion
rates, and a better intervention effect.
Results: We drew four lessons: 1) difficulties identifying potentially eligible patients threaten the viability of practical
trials of DAs; 2) to improve the recruitment yield, recruit clinicians and patients for the study at the clinic, just
before their visit; 3) approaches that improve recruitment may be associated with reduced retention and survey
response; and 4) procedures that involve working closely with the practice may improve recruitment and may also
affect the quality of the implementation of the interventions.
Conclusion: Success in practice-based trials in usual primary care including rural clinics may require the smallest
possible research footprint on the practice while implementing a streamlined protocol favoring in-clinic, in-person
interactions with clinicians and patients.
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Shared decision making (SDM) and patient-centered
care are now widely recognized as desirable components
of a high quality healthcare system. A systematic review
of 86 randomized trials confirms the ability of SDM
tools or decision aids (DAs) to promote patient involve-
ment in decision making [1]. This has motivated policies
and legislation promoting patient participation in deci-
sion making and the use of DAs in practice, including
the Patient Protection and Affordable Care Act (2010),
the so-called US healthcare reform law [2]. How best to
implement these effective tools in clinical practice re-
mains uncertain [3]. Moreover, DA trials have been
conducted primarily in university settings and often out-
side of clinical contexts, distinct from primary care prac-
tices in general and of rural practices in particular [4].
The conduct of randomized controlled trials (RCTs) in
usual practice settings can present challenges, particu-
larly concerning patient recruitment. Many clinical trials
either fail to meet recruitment goals within the intended
timeframe or do not meet recruitment goals at all [5-9].
This can pose ethical and financial challenges such as
limiting the statistical strength of study results, increas-
ing study costs, and exposing study participants to risk
despite a diminished ability to answer the study question
with sufficient precision [5,8]. Over 50% of studies have
been reported to require extensions due to insufficient
recruitment [10]. While a Cochrane systematic review
identified telephone reminders to non-responders, opt-
out procedures, and financial incentives as potential
methods for increasing enrollment [5], there is limited
evidence regarding generalizable strategies to improve
recruitment [9,11]. Furthermore, RCTs of DA tools in
rural practices face particular challenges: clinical sites
can be separated by vast distances, rural clinicians may
lack familiarity with SDM and DA tools and with partici-
pating in clinical care research, and patients are less
likely to be insured (have unfettered access to the prac-
tice) and have experience with participation in research
activities [4].
To evaluate the effectiveness of our diabetes-focused
DAs in primary care clinics in rural and suburban south-
eastern Minnesota, USA, we undertook a multicenter,
pragmatic RCT. This paper describes some lessons we
have drawn from its conduct.
Methods
Detailed accounts of the study protocol are published
elsewhere and are briefly reported below [12].
Study design and setting
We conducted a cluster randomized, practical, multicenter
trial, enrolling rural and suburban primary care practices
in the Midwestern United States. Participating primarycare practices were matched by size and randomized to
the intervention or usual care (UC) arm by an external
statistician. Practices were randomized to one of three
DAs (available at http://shareddecisions.mayoclinic.org):
Statin Choice or Aspirin Choice (that is, cardiovascular
medication choices) or Diabetes Medication Choice, serv-
ing as control for the practices allocated to the other DA.
Institutional Review Boards (IRBs) at participating sites
approved all study procedures. The study is registered at
ClinicalTrials.gov (Identifier: NCT01029288).
Participants
Primary care practices were considered for enrollment if
they were located within rural and suburban areas, and
within a 50-mile radius from the research team’s primary
location in Rochester, MN, USA. Clinicians (that is, phy-
sicians, nurse practitioners, physician assistants) from
participating practices were eligible if they provided care
for adults with type 2 diabetes. English speaking patients
(≥18 years old) were considered eligible if they had type
2 diabetes, were considered by their clinician to have in-
adequate glucose control and be at the top of the dose
of medication related to the management of their chol-
esterol or diabetes, and had no major barriers to provid-
ing written informed consent. In other words, we sought
patients in whom it was necessary and possible to have a
discussion about medications. Additional criteria were
required according to each of the arms, and a flowchart
was developed to facilitate the process of identification
of eligible patients (available at http://www.ncbi.nlm.nih.
gov/pmc/articles/PMC3468357/figure/F2/) [12].
Identification and selection for recruitment
Primary care practices were contacted at which in-
vestigators had a direct link or knew potential clinical
champions to seek interest in participating in the trial.
Primary care clinicians were approached before the start
of the study during an initial meeting between practice
staff and research team members. Clinicians were offered
to participate in the study and signed written informed
consent documents during this meeting. Clinicians who
chose not to participate or were absent from this meeting
were not approached again. No financial incentive was of-
fered to clinicians or practices.
Study coordinators sought eligible patients with up-
coming appointments with participating clinicians using
the practice’s diabetes registry and medical records. They
contacted eligible patients by telephone 1 week before
their scheduled appointment. After three unsuccessful
phone calls, it was assumed these patients declined par-
ticipation. To enroll patients who had agreed to partici-
pate, study coordinators traveled to practice sites to
obtain written consent, and proceed with study enroll-
ment and assessment. Mailed follow-up surveys and
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study coordinator. A two-dollar bill (US$2) was included
with each follow-up survey sent to participating patients.
Trial strategies
The study team aimed to keep the disruption of work-
flow and burden on clinicians and staff to a minimum.
Study coordinators, who were located in a central office
away from the study sites, were responsible for all as-
pects of patient recruitment and follow-up. Onsite visits
by study coordinators were limited to when eligible pa-
tients had previously agreed to meet. Clinicians were no-
tified by email when one of their patients was eligible for
the study and that a study coordinator would be present
at the upcoming appointment. Further contact was lim-
ited, and patient and clinician surveys were kept to a
minimal number and length.
Intervention and usual care (UC)
The intervention consisted of the use of a DA (Diabetes
Medication or Statin or Aspirin Choice) by patients and
their primary care clinicians during a regular clinical en-
counter [12-15]. Clinicians were briefly trained by the
investigators during an initial meeting, and study team
members remained available for one-on-one demonstra-
tion when needed. Online access to a brief video clip
and storyboard demonstrating the use of DAs was also
provided. Clinicians were handed the DA just before a
clinical encounter with participating patients. Participat-
ing clinicians and patients in the UC arm discussed
medication regimens as usual. All DAs and related ma-
terial can be found online at http://shareddecisions.
mayoclinic.org/.
Data collection and outcome measures
Surveys were administered to both clinicians and pa-
tients immediately following the visit, and follow-up sur-
veys were sent to patients by mail 3 and 6 months
following the visit. Information about diabetes-related
care was extracted from the medical record. With clin-
ician and patient approval, we videotaped encounters
using a small, easy-to-use video camera. Primary out-
come measures were: the patient’s level of comfort with
the decision made (measured using the decisional con-
flict scale (DCS) [16]), the extent to which clinicians in-
volved patients in the decision making process (using
the observing patient involvement (OPTION) scale
[17]), and patient’s knowledge of risks and benefits rele-
vant to the decision they faced. Other outcomes in-
cluded patient satisfaction, quality of life, degree of
metabolic control, adherence to medication, and clini-
cian’s satisfaction [12]. We reviewed video recordings of
encounters using checklists specific to each DA to assess
the fidelity with which clinicians were able to use theDA as intended or to assess the extent to which clini-
cians demonstrated similar behaviors when providing
UC suggesting potential contamination across arms.
Sample size and analysis
To detect a meaningful difference in our primary out-
come of interest (decisional comfort), we needed to en-
roll eight practices and 240 patients. Before study start,
we ascertained the eligible patient population from ana-
lyses of practice databases and estimated that a 9-month
period would be needed to achieve our recruitment goal.
Details of the analysis plan and results are reported else-
where [12,13].
Identification of lessons learned
The project manager and the lead study coordinator
kept detailed notes during the conduct of the trial. Mi-
nutes were maintained for the periodic research meet-
ings in which investigators and study personnel reviewed
study progress and solved problems as they arose. Com-
ments and observations relayed to the team in person or
through electronic communication by study participants
were also saved. All material was maintained and issues
tracked. Some issues were identified as impactful enough
that they led to changes in the conduct of this trial and/
or affected the design and execution of the team’s other
trials of DAs in primary care; these issues are presented
here as lessons learned.
Results
Lesson 1: difficulties identifying potentially eligible
patients threaten the viability of practical trials of
decision aids (DAs)
We designed our study with the intention to optimize
recruitment and minimize bias, while considering the
time, effort, and commitment that study participation
demands of practices and clinicians. Each practice was
allocated to a specific DA within the intervention arm,
while serving as the UC arm for the remaining DAs.
This design allowed the opportunity for each practice to
take part in the intervention and eliminated the need for
any practice to serve only as an UC arm site. Moreover,
this design ensured that DAs were implemented in all
participating practices, preventing randomization from
fortuitously allocating the implementation of DAs pref-
erentially to more flexible and organized practices. How-
ever, we had not anticipated how arduously our study
coordinators would have to work to identify eligible pa-
tients. They had to review the medical record of each
potentially eligible patient, ascertaining the diagnosis of
diabetes, HbA1c value, diabetes medication history, use
of aspirin, and use of statins. This time-intensive process
took about 25 minutes per candidate. In particular, de-
termining whether patients were taking aspirin required
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scription and information about its use is therefore not
included in the e-prescription section of the medical rec-
ord. Coordinators found that most candidates were
already taking aspirin. In consideration of the significant
amount of time required to review aspirin information
and the limited number of available patients not taking
aspirin, the study team decided to remove the Aspirin
Choice DA approximately 1 month into the study, at
which point only two patients had been assigned to this
DA. This modification streamlined the process for identi-
fying eligible patients and considerably reduced screening
time required of study coordinators.Lesson 2: to improve the recruitment yield, recruit
clinicians and patients for the study at the clinic, just
before their visit
We contacted known rural and suburban primary care
practices and presented the study to practice members:
eight practices agreed and three declined study partici-
pation. In keeping with our objective to be minimally
disruptive, clinicians at participating practices were ap-
proached individually only once to invite their participa-
tion. Figure 1 (left) shows the study performance during











Declined at clinic 
5 
















































Figure 1 Enrollment flow associated with the recruitment approaches
modified approach. DAD, decision aids for diabetes.of 121 eligible patients and the successful enrollment of
48 patients.
Over time, we saw plateauing of the eligible patient
population (Figure 2) and realized that trial enrollment
targets could not be met, leading to a revision of clin-
ician and patient recruitment protocols. The study team
decided not to re-contact clinicians who had already de-
clined participation. Modifying patient eligibility criteria
was considered, but expansion of the eligibility criteria
would threaten the pertinence of the intervention. Thus, it
was determined that further attempts at patient enrollment
would not be an effective use of resources, and recruitment
was discontinued at the initial eight sites.
Four new suburban practices were approached using a
different method (Figure 1, right). Clinicians were offered
the opportunity to give written informed consent at the
initial meeting with the study team, as in the original re-
cruitment procedure. However, in scanning registries and
records for potentially eligible patients, study coordinators
considered all practice patients with diabetes with upcom-
ing appointments, only avoiding patients from clinicians
who had declined participation at the initial visit. If an eli-
gible patient was identified within the panel of a clinician
who had not yet given consent for participation, the study
coordinators approached the clinician at their next en-
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Figure 2 Eligibility and enrollment of patients over time in the DAD trial. Left, original design; right, in-clinic modified approach. DAD,
decision aids for diabetes.
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the study if the timing was not appropriate (study coord-
inator could approach them again for future eligible pa-
tients), or declining participation definitively. In these
practices, we discontinued phone interviews with candi-
date patients, instead approaching them immediately as
they appeared for their scheduled appointment at the
clinic. During the interview in the clinic examination
room – unhurried, quiet, private, and face-to-face – study
coordinators reviewed details of the study and obtained
written informed consent. Table 1 offers a summary of the
differences between the two recruitment approaches.
The in-clinic approach in the four new sites continued
for 5 months. Figure 1 (right) shows the study perform-
ance during the 5 months of recruitment leading to the
identification of 86 eligible patients and the successful
recruitment of 62 of them. Thus, the in-clinic approach
was superior to the original approach in proportion of
eligible patients enrolled: 62 of 86 (72%) compared with
48 of 121 (40%) with the original approach. This was
due to a higher proportion of eligible patients who could
not be reached using the telephone discussion method
and to fewer patients who declined to participate when
invited in person (Figure 1).Table 1 Comparison of recruitment methods
Original approach (n = 8 sites)
Clinician
recruitment
Primary care clinicians approached and consented before st
Patient
recruitment




Screening for eligible patients from listings of upcoming dia
appointments with participating cliniciansLesson 3: approaches that improve recruitment may be
associated with reduced retention and survey response
Given the slow and laborious enrollment of patients into
the study, participant retention was deemed essential
since loss to follow-up would further impede results
[18]. Survey participation rates for clinicians and patients
were compared between the two approaches (Table 2).
Significant differences were noted in survey return rates
for 3-month follow-up (84% versus 66%, P = 0.03) and 6-
month follow-up (71% versus 47%, P = 0.01), with the ori-
ginal approach yielding higher return rates. Clinician post-
visit survey return rates also differed (100% versus 86%, P
<0.01), with higher return rates at the initial practices.
Thus, improvements in recruitment may have come at the
expense of the intention-to-treat principle.
Lesson 4: procedures that involve working closely with the
practice may improve recruitment and may also affect the
quality of the implementation of the interventions
The post-encounter surveys asked patients and clinicians
about their encounter experiences, specifically whether a
discussion regarding medication occurred. No difference
was found in the UC arms between the recruitment
approaches, but large differences were evident in theIn-clinic approach (n = 4 sites)
art of study Primary care clinicians approached and consented before
start of study and/or at first eligible study visit
e 1 week Eligible patients recruited by study coordinators in person
at appointment
betes Screening for eligible patients from registry of all diabetic
patients at site
Table 2 Outcome completion rate associated with the







(% of eligible set)
48 (40) 62 (72) <0.0001
Patient survey
Patient post-visit survey return
rate, n (%)a
45 (100) 54 (93) 0.07
Patient 3-month survey return
rate, n (%)
38 (84) 38 (66) 0.03
Patient 6-month survey return
rate, n (%)
32 (71) 27 (47) 0.01
Clinician survey
Clinician survey return rate,
n (%)
45 (100) 50 (86) 0.01
Qualitative interview
Patients that agreed to
qualitative interview, n (%)
18 (40) 22 (38) 0.96
Encounter video recording
Patients that agreed to have
the encounter video-recorded,
n (%)
19 (42) 23 (40) 0.79
aBased on 45 and 58 patients used in analysis, respectively. DAD decision aids
for diabetes.
Table 3 Implementation and integration of the decision
aid (DA) compared to usual care (UC) in practices








18/45 (40) 23/58 (40) 0.89
Fidelity score, mean (SD)
UC 11.4 (22.7) 22.3 (16.6) 0.97
DA 65.2 (28.5) 66.3 (26.2) 0.24
OPTION score, mean (SD)
UC 16.3 (13.9) 34.8 (28.9) 0.10
DA 38.7 (21.1) 62.8 (8.5) 0.003
Patient-reported outcomes, n/N (%)
Had a discussion about medication
UC 11/27 (41) 10/20 (50) 0.57
DA 10/18 (56) 30/34 (88) 0.02
Clinician-reported outcomes, n/N (%)
Ease of use of DA 11/14 (79) 28/33 (85) 0.68
Easy to integrate into the
practice
6/13 (46) 32/33 (97) <0.01
DA decision aid, DAD decision aids for diabetes, OPTION observing patient
involvement; UC usual care.
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the original sites, only 56% of patients in the DA arm
reported a discussion, while 88% of patients reported a
discussion at the in-clinic recruitment sites (P = 0.02;
Table 3). Although a similar proportion of clinicians
recruited through the two approaches reported the DA
was easy to use (79% versus 85%, P = 0.7) and
implemented their allocated intervention with similar fi-
delity, a much larger proportion found it easier to inte-
grate the DA into their practice in the in-clinic group
(46% versus 97%, P <0.01). Clinicians in the first eight
sites in both control and intervention arms achieved sig-
nificantly less patient involvement as observed on video-
recorded encounters than clinicians recruited through
the in-clinic approach (mean OPTION score 16.3 versus
34.8 in the control arms; 38.7 versus 62.8 in the DA
arms, respectively; Table 3).
Discussion
Our findings
For this RCT in which we implemented an intervention
into primary care practices, two methods were employed
for recruitment that yielded different results. Both ap-
proaches minimized burden to participating sites and
clinicians by placing the responsibility of recruitment on
the study team, which has been shown to facilitate re-
cruitment rates in a systematic review [19]. The original
approach to clinician and patient recruitment was
implemented at eight primary care sites. The rationalewas to enroll committed clinicians in order to minimize
disruption to the practice of less-interested colleagues.
This process also made study coordinators more effi-
cient by limiting the search for eligible patients to the
panel of participating clinicians and limiting travel to
meet with patients who had already expressed interest in
participating. With the processes used at the subsequent
four sites, the focus was an in-clinic approach for clin-
ician enrollment, a more laborious patient identification
process screening all the practice patients, and a more
constant presence of study coordinators at the sites.
These approaches differed in efficiency, recruitment, re-
tention, implementation of the intervention, and out-
comes. There are some potentially plausible explanations
for our findings that could represent lessons learned for
us and other investigators conducting clustered trials of
practice interventions.
Before turning our attention to those lessons, we must
remember that any comparisons drawn here are those of
an observational study of the implementation of a pilot
randomized trial. Given that the practices were not ran-
domly allocated to the recruitment approaches, we can-
not draw causal inferences linking the recruitment
approaches with the outcomes observed. The validity of
hypotheses linking differences in the clinics in which we
used different recruitment methods – differences in lo-
cation, interest in the study, or practice style – with re-
cruitment outcomes weaken our inferences attributing
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proaches used.
Phone contact to initiate enrollment
While it may be efficient, calling patients at home to invite
them to participate in the study may have hindered re-
cruitment: almost two in every five patients declined with
this method. Furthermore, we also missed enrollment op-
portunities because we considered patients had declined
participation if they could not be reached by telephone or
return our call after three attempts. If this method must
be used – and there is a strong support for patients to re-
flect on the pros and cons of participation away from the
anxieties of a clinic appointment – perhaps an introduc-
tion to the study before the telephone call, such as by an
informational mail-out flyer, may have increased patients’
willingness to participate [19,20].
Efficient use of study coordinators
Limiting patient search to the panels of participating cli-
nicians certainly improved the efficiency of study coordi-
nators, as did contacting potentially eligible patients in
advance by telephone and limiting travel to consent pa-
tients who had already agreed to participate. Although
this approach resulted in lower enrollment and higher
decline rates than the more time-intensive in-clinic re-
cruitment method, it yielded higher retention rates and
significantly higher survey response rates. This may in-
dicate a more thought-out decision to participate and a
higher level of patient engagement when more time is
afforded for building rapport with potential partici-
pants, as has been demonstrated in other studies
[21,22]. Since we did not try the in-clinic approach in
these clinics, we cannot know whether it would have
had the same consequences it did on the clinics we
approached later, or if clinicians and their patients
would have found it acceptable.
Before study implementation, we reviewed each site’s
diabetes registry and found sufficient patients in partici-
pating practices to meet our accrual goal. However, we
found fewer eligible patients than needed to meet our
goal (Figure 1), primarily because some clinicians at
these practices declined to participate, excluding their
patients from this study. This contributed to limited ac-
crual at a number of sites, with less than three patients
enrolled at sites where only one or two clinicians agreed
to participate. Also, to avoid disturbances, we did not re-
turn to the site to try to recruit clinicians who had de-
cided not to participate after the initial onsite training
session. Perhaps the ongoing interaction between study
coordinators and clinicians recruited through the in-
clinic approach reinforced clinicians’ understanding of
the work, thus resulting in better integration of the DA
and of the trial procedures into the practice, higherlevels of patient engagement in decision making, and
more recognition by patients that a discussion regarding
medication took place [23].
We believe that the ideal approach to successfully
conducting a practice-based trial may depend on the na-
ture of patients, clinicians, and practices of the interven-
tions tested, and of the goals of the trial; that is, where it
lies on the continuum from explanatory (testing efficacy
under tightly controlled conditions to advance science)
to practical (testing effectiveness under usual conditions
to support the evidence needs of decision makers) [24].
We think our findings support the notion that strategies
to identify and address barriers to clinical trial recruit-
ment and retention while optimizing resource utilization
involve difficult tradeoffs and may have unintended con-
sequences, including affecting the effectiveness of the
intervention, particularly when participant motivation
matters.
Conclusions
Successful practice-based trials in rural clinics require
methodological decisions associated with tough tradeoffs.
As originally designed, poor clinician recruitment severely
restricted access to eligible patients, limited contact of re-
searchers with the practice may have reduced clinician
motivation, and patient recruitment practices may have
recruited more ‘high quality’ patients, but too few to meet
recruitment targets.
Although it takes more time, more work, and more
travel for study coordinators, onsite recruitment offers im-
portant advantages. Onsite recruitment increased the face
time investigators had with practice personnel, increasing
familiarity and collaboration. A streamlined study design
and recruitment protocol favoring in-person interactions
with clinicians and patients has the potential to promote
better enrollment and integration of the trial procedures
into the fabric of the practices. Ultimately, the value of this
approach is subject to judgments that we expect the in-
sights presented here will help inform.
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